|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4152 | |
| A61P 25/00 |
| (11) | Number of the document | 1793821 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05772671.3 |
| Date of filing the European patent application | 2005-08-10 | |
| (97) | Date of publication of the European application | 2007-06-13 |
| (45) | Date of publication and mention of the grant of the patent | 2018-10-31 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2005/014969 |
| Date | 2005-08-10 |
| (87) | Number | WO 2006/016707 |
| Date | 2006-02-16 |
| (30) | Number | Date | Country code |
| 2004233635 | 2004-08-10 | JP |
| (72) |
YUKI, Satoshi, c/o MITSUBISHI PHARMA CORPORATION, JP
NAKANO, Takuma, c/o MITSUBISHI PHARMA CORPORATION, JP
SUZUKI, Hiroko, c/o MITSUBISHI PHARMA CORPORATION, JP
|
| (73) |
Mitsubishi Tanabe Pharma Corporation,
2-10, Dosho-machi 3-chome Chuo-ku, Osaka-shi Osaka 541-8505,
JP
|
| (54) | PYRAZOLONE COMPOUNDS FOR TREATING CEREBROVASCULAR DISORDERS |
| PYRAZOLONE COMPOUNDS FOR TREATING CEREBROVASCULAR DISORDERS |